Systematic Identification of Molecular Signatures Dictating Therapeutic Effects of Clinically First‐Line Chemotherapy Regimens for Human Gastric Cancer Patients Based on Organoid Model

Documenti analoghi

• Gastric Cancer: Pathobiology and Therapeutics
  di: Ruixian Yu, et al.
  Pubblicazione: (2026)
• FBXW7 Targets the SPT6‐ΔNp63 Axis for Degradation to Inhibit Esophageal Tumorigenesis Induced by 4‐Nitroquinoline N‐Oxide
  di: Jiagui Zhang, et al.
  Pubblicazione: (2026)
• PD‐1/PD‐L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First‐Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
  di: Riqing Huang, et al.
  Pubblicazione: (2025)
• Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
  di: Jiayi Jin, et al.
  Pubblicazione: (2025)
• Systematic Proteomic Characterization of EV‐A71‐Infected Mice Identifies Dynamic Molecular Changes and Therapeutic Targets
  di: Wanjun Peng, et al.
  Pubblicazione: (2026)